ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging ...

Following the announcement that NHS England is to be abolished, Siva Anandaciva considers the implications and why at the ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8524 ...

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an inhibitor of the ...

DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...

Addison’s disease treatment market is growing with advancements in hormone replacement therapies, including glucocorticoids and mineralocorticoids, ensuring better disease management by 2035.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Impact and progress Frontiers' impact Progress Report 2022 All annual reports ...